A Multi center, Double-Blind, Randomized, Placebo-Controlled Trial of  terjemahan - A Multi center, Double-Blind, Randomized, Placebo-Controlled Trial of  Bahasa Indonesia Bagaimana mengatakan

A Multi center, Double-Blind, Rando

A Multi center, Double-Blind, Randomized, Placebo-
Controlled Trial of Rituximab Therapy for Childhood-
Onset Complicated FRNS/SDNS
To evaluate the efficacy and safety of rituximab inchildhood onset complicated FRNS/SDNS,amulti center,double-blind,
randomized, placebo-controlled trial was carried out by the
Research Group of Childhood-onset Refractory Nephrotic
Syndrome (RCRNS) in Japan (RCRNS01) (Clinical Trials
Registry ID: UMIN000001405). At the same time, an open-
label, multicenter, pharmacokinetic trial (RCRNS-02)
(Clinical Trials Registry ID: UMIN000001406) was also
carried out. These two trials were investigator-initiated
clinical trials, which sought to gain approval from the Min-
istryofHealth,LabourandWelfare,Japantomakerituximab
available for patients with childhood-onset complicated
FRNS/SDNS. These trials were supported by a Health and
Labor Sciences Research Grant for the Large Scale Clinical
Trial Network Project (CCT-B-2001). The study design of
RCRNS01 is shown in Fig. 1. The protocol for RCRNS01 is
available at http://www.med.kobe-u.ac.jp/pediat/pdf/rcrn01.
pdf.Whenpatientsdevelopedrelapseofnephroticsyndrome,
0/5000
Dari: -
Ke: -
Hasil (Bahasa Indonesia) 1: [Salinan]
Disalin!
A Multi center, Double-Blind, Randomized, Placebo-Controlled Trial of Rituximab Therapy for Childhood-Onset Complicated FRNS/SDNSTo evaluate the efficacy and safety of rituximab inchildhood onset complicated FRNS/SDNS,amulti center,double-blind,randomized, placebo-controlled trial was carried out by theResearch Group of Childhood-onset Refractory NephroticSyndrome (RCRNS) in Japan (RCRNS01) (Clinical TrialsRegistry ID: UMIN000001405). At the same time, an open-label, multicenter, pharmacokinetic trial (RCRNS-02)(Clinical Trials Registry ID: UMIN000001406) was alsocarried out. These two trials were investigator-initiatedclinical trials, which sought to gain approval from the Min-istryofHealth,LabourandWelfare,Japantomakerituximabavailable for patients with childhood-onset complicatedFRNS/SDNS. These trials were supported by a Health andLabor Sciences Research Grant for the Large Scale ClinicalTrial Network Project (CCT-B-2001). The study design ofRCRNS01 is shown in Fig. 1. The protocol for RCRNS01 isavailable at http://www.med.kobe-u.ac.jp/pediat/pdf/rcrn01.pdf.Whenpatientsdevelopedrelapseofnephroticsyndrome,
Sedang diterjemahkan, harap tunggu..
Hasil (Bahasa Indonesia) 2:[Salinan]
Disalin!
Sebuah pusat multi, Double-Blind, Acak, plasebo
terkontrol Pengadilan Rituximab Terapi untuk masa kecil
Onset Complicated SNKS / SDN
Untuk mengevaluasi efikasi dan keamanan rituximab inchildhood onset rumit SNKS / SDN, pusat amulti, double-blind,
acak, plasebo percobaan -controlled dilakukan oleh
Research Group of Childhood-onset tahan panas Nefrotik
Syndrome (RCRNS) di Jepang (RCRNS01) (Clinical Trials
Registry ID: UMIN000001405). Pada saat yang sama, sebuah terbuka-
label, multicenter, percobaan farmakokinetik (RCRNS-02)
(Clinical Trials Registry ID: UMIN000001406) juga
dilakukan. Kedua percobaan yang penyidik-dimulai
uji klinis, yang berusaha untuk mendapatkan persetujuan dari kementerian
istryofHealth, LabourandWelfare, Japantomakerituximab
tersedia untuk pasien dengan masa-onset rumit
SNKS / SDN. Percobaan ini didukung oleh Kesehatan dan
Ilmu Tenaga Kerja Penelitian Hibah Skala Besar Clinical
Percobaan Proyek Jaringan (CCT-B-2001). Desain penelitian dari
RCRNS01 ditunjukkan pada Gambar. 1. Protokol untuk RCRNS01 adalah
tersedia di http://www.med.kobe-u.ac.jp/pediat/pdf/rcrn01.
pdf.Whenpatientsdevelopedrelapseofnephroticsyndrome,
Sedang diterjemahkan, harap tunggu..
 
Bahasa lainnya
Dukungan alat penerjemahan: Afrikans, Albania, Amhara, Arab, Armenia, Azerbaijan, Bahasa Indonesia, Basque, Belanda, Belarussia, Bengali, Bosnia, Bulgaria, Burma, Cebuano, Ceko, Chichewa, China, Cina Tradisional, Denmark, Deteksi bahasa, Esperanto, Estonia, Farsi, Finlandia, Frisia, Gaelig, Gaelik Skotlandia, Galisia, Georgia, Gujarati, Hausa, Hawaii, Hindi, Hmong, Ibrani, Igbo, Inggris, Islan, Italia, Jawa, Jepang, Jerman, Kannada, Katala, Kazak, Khmer, Kinyarwanda, Kirghiz, Klingon, Korea, Korsika, Kreol Haiti, Kroat, Kurdi, Laos, Latin, Latvia, Lituania, Luksemburg, Magyar, Makedonia, Malagasi, Malayalam, Malta, Maori, Marathi, Melayu, Mongol, Nepal, Norsk, Odia (Oriya), Pashto, Polandia, Portugis, Prancis, Punjabi, Rumania, Rusia, Samoa, Serb, Sesotho, Shona, Sindhi, Sinhala, Slovakia, Slovenia, Somali, Spanyol, Sunda, Swahili, Swensk, Tagalog, Tajik, Tamil, Tatar, Telugu, Thai, Turki, Turkmen, Ukraina, Urdu, Uyghur, Uzbek, Vietnam, Wales, Xhosa, Yiddi, Yoruba, Yunani, Zulu, Bahasa terjemahan.

Copyright ©2025 I Love Translation. All reserved.

E-mail: